Cargando…
Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
Genomic amplification of 19q12 occurs in several cancer types including ovarian cancer where it is associated with primary treatment failure. We systematically attenuated expression of genes within the minimally defined 19q12 region in ovarian cell lines using short-interfering RNAs (siRNA) to ident...
Autores principales: | Etemadmoghadam, Dariush, George, Joshy, Cowin, Prue A., Cullinane, Carleen, Kansara, Maya, Gorringe, Kylie L., Smyth, Gordon K., Bowtell, David D. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980490/ https://www.ncbi.nlm.nih.gov/pubmed/21103391 http://dx.doi.org/10.1371/journal.pone.0015498 |
Ejemplares similares
-
Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
por: Gorringe, Kylie L., et al.
Publicado: (2010) -
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
por: Helland, Åslaug, et al.
Publicado: (2011) -
Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin
por: Zhang, Chao, et al.
Publicado: (2019) -
Clonogenic Assay of Gastric Adenocarcinoma Stem Cells: Clonogenic Assay, Stomach Cancer
por: Kim, Hoon Kyo, et al.
Publicado: (1987) -
Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
por: Cocco, Emiliano, et al.
Publicado: (2016)